from Yahoo Finance https://ift.tt/2XCUHLr

Gilead is aiming to supply enough of the drug by the end of the year to treat more than 2 million COVID-19 patients, and agreed to send nearly all of its remdesivir supply to the United States through September. Earlier this week, a bipartisan group of state attorneys general urged the U.S. government to allow other companies to make Gilead’s remdesivir, to increase its availability and lower the price of the antiviral drug. Gilead said its manufacturing network for the drug had grown to more than 40 companies in North America, Europe and Asia to add capacity.

from Yahoo Finance https://ift.tt/2XxUaur

VANCOUVER, BC, Aug. 5, 2020 /CNW/ – Pan American Silver Corp.

from Yahoo Finance https://ift.tt/30ylGdg

President Trump has issued executive orders that could ban TikTok and WeChat within 45 days. Yahoo Finance’s Akiko Fujita discusses with Alexis Christoforous and Brian Sozzi.

from Yahoo Finance https://ift.tt/33OM6cP

Jeff Lawson became the CEO of Twilio Inc. (NYSE:TWLO) in 2008, and we think it's a good time to look at the…

from Yahoo Finance https://ift.tt/3gDM3Uq

from Yahoo Finance https://ift.tt/30CNE7w

A new slugfest has erupted between two of Silicon Valley's biggest corporations. Apple, after repeatedly rejecting Facebook Gaming app for iOS devices, finally approved the social giant's app for the App Store. However, Facebook had to strip out games entirely — allegedly because of Apple's preconditions for it to be published in the App Store. […]

from Yahoo Finance https://ift.tt/2C8kgN9

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose…

from Yahoo Finance https://ift.tt/2Pxc3oD

The Department of Labor’s July jobs report was released at 8:30 a.m. ET Friday.

from Yahoo Finance https://ift.tt/2Dll0PE

Japan plans to buy AstraZeneca Plc’s experimental COVID-19 vaccine and fund a local company to manufacture Novavax’s vaccine candidate, ramping up its stockpile plan as it battles surging infections. Japan will order 120 million doses of the experimental vaccine developed by the British pharmaceutical company, beginning with 30 million doses by March next year. Separately, Takeda Pharmaceutical said on Friday it would manufacture and sell up to 250 million doses of Novavax’s COVID-19 vaccine candidate every year in Japan, with funding support from the government.

from Yahoo Finance https://ift.tt/2F2qZJB